膜性肾病的免疫抑制治疗
摘要
特发性膜性肾病（IMN）本身不是一个均一性的疾病，在临床表现、发展经过及预后等方面不同患者差异颇大，治疗亦有其特殊性，应重视基础治疗，长期坚持，分阶段用药，因人而异，强调个体化治疗方案，应用免疫抑制剂治疗前应权衡利弊，充分考虑疗效／风险之比，减少副作用与并发症，避免过分追求尿蛋白的阴转而长期过度使用糖皮质激素和免疫抑制剂的倾向。
出处
《国际泌尿系统杂志》
2007年第2期231-234,共4页
International Journal of Urology and Nephrology
参考文献18
-
1du Buf- Vereijken PW, Branten AJ, Wetzels JF. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis, 2005, 46: 1012 - 1029.
-
2Imai H. Medical decision - making in membranous nephropathy: how to use limited clinical research evidence in patient management. Clin Exp Nephrol, 2005, 9:206-211.
-
3Austin HA, Falk RJ. Idiopathic membranous nephropathy. In: Brady HR & Wilcox CS eds. Therapy in nephrology and hypertension.Philadelphia: WB Saunders, 2003. 189-198.
-
4Couser WG. Membranous nephropathy: a long road but well traveled.J Am Soc Nephrol, 2005, 16:1184-1187.
-
5Cattran D. Management of membranous nephropathy: when and What for treatment. J Am Soc Nephrol, 2005, 16:1188-1194.
-
6Passerini P, Ponticelli C. Corticosteroids, cyclophosphamide, and chlorambucil therapy of membranous nephropathy. Semin Nephrol,2003, 23:355-361.
-
7Ponticelli C, Passerini P, Salvadori M, et al. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent venus synthetic adrenocortlcotropic hormone in idiopathic membranous nephropathy.Am J Kidney Dis, 2006, 47:233-240.
-
8Goumenos DS, Kalliakmani P, Tsakas S, et al. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. Clin Nephrol, 2004,61:17-24.
-
9Cattran DC. Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy. Semin Nephrol, 2003, 23:272-277.
-
10Szeto CC, Leung CB, Lai FM, et al. Tacrolimus in resistant primary membranous nephropothy - a report of 3 cases. Clin Nephrel,2003, 59:293 - 296.
-
1郭红霞,史均宝,陆敏,张爱华,王悦,郑丹侠.环磷酰胺联合糖皮质激素治疗以肾病综合征为临床表现的特发性膜性肾病疗效[J].临床荟萃,2015,30(1):104-106. 被引量：33
-
2丁蓓蓓.两种方案治疗特发性膜性肾病的疗效比较[J].中国基层医药,2014,21(21):3238-3241. 被引量：7
-
3李娟,闫丽静,杨林.抗足细胞抗体在原发性膜性肾病发病机制中的作用[J].中华肾脏病杂志,2012,28(7):544-547.
-
4雷丽,李志湘,廖湘平.特发性膜性肾病足细胞抗原的研究进展[J].中国医师杂志,2016,18(3):473-476. 被引量：4
-
5王文娟.百令胶囊联合厄贝沙坦治疗膜性肾病的疗效观察[J].临床合理用药杂志,2014,7(24):37-38. 被引量：8
-
6蒋丰强.腹腔镜治疗胆囊结石合并胆囊萎缩的体会[J].实用临床医学（江西）,2010,11(6):64-64. 被引量：1
-
7张瑶,曹灵.膜性肾病的发病机制新进展[J].山东医药,2009,49(52):106-107. 被引量：1
-
8李雷婷,李冰.特发性膜性肾病治疗进展[J].临床荟萃,2013,28(3):342-347. 被引量：9
-
9郑丹侠,宋燕,史均宝,韩庆烽,张爱华.原发性膜性肾病85例治疗回顾性纷析[J].临床荟萃,2005,20(20):1145-1147. 被引量：2
-
10徐金升,何雷,张胜雷.2015年肾脏病重要研究进展[J].临床荟萃,2016,31(2):168-174. 被引量：1
